• DOI:10.1002/jbmr.335
Corpus ID: 206009879

Discontinuation of odanacatib and other osteoporosis treatments: Here today and gone tomorrow?

@article{Bauer2011DiscontinuationOO,
  title={Discontinuation of odanacatib and other osteoporosis treatments: Here today and gone tomorrow?},
  author={D. Bauer},
  journal={Journal of Bone and Mineral Research},
  year={2011},
  volume={26}
}

D. Bauer

Published 2011

Medicine

Journal of Bone and Mineral Research

The options available for effective osteoporosis treatment continue to grow. Because of the large number of treatment options, many clinicians, particularly in primary care, are uncertain about when to start therapy, which drug to use, and when to stop. The issue of when to stop antifracture therapy is now front and center as evidence accumulates that the antifracture benefits of some treatments persist after discontinuation and as patients increasingly voice concerns about possible rare but… CONTINUE READING

View on Wiley

onlinelibrary.wiley.com

Save to Library

Create Alert

Cite

Launch Research Feed